⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Pfizer Responds to Delaware Chancery Court Ruling
businesswire.com
PFE
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
businesswire.com
PFE
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
businesswire.com
PFE
MTSR
Pfizer Addresses Proposal for Metsera
businesswire.com
PFE
NVO
MTSR
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
prnewswire.com
IOBT
NVS
BCAX
PFE
Precision Oncology Approaches Drive $312B Market Transformation
prnewswire.com
GTBP
NRIX
GRAL
CCCC
PFE
GTBP
NRIX
GRAL
CCCC
PFE
ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
businesswire.com
PFE
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
businesswire.com
PFE
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
businesswire.com
PFE
Pfizer Declares Fourth-Quarter 2025 Dividend
businesswire.com
PFE